1. Home
  2. IMPP vs EMBC Comparison

IMPP vs EMBC Comparison

Compare IMPP & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imperial Petroleum Inc.

IMPP

Imperial Petroleum Inc.

N/A

Current Price

$5.28

Market Cap

234.7M

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

N/A

Current Price

$5.83

Market Cap

199.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMPP
EMBC
Founded
1981
1924
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.7M
199.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
IMPP
EMBC
Price
$5.28
$5.83
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
352.0K
1.8M
Earning Date
05-22-2026
05-05-2026
Dividend Yield
N/A
6.88%
EPS Growth
N/A
20.90
EPS
N/A
1.03
Revenue
N/A
N/A
Revenue This Year
$51.79
$1.17
Revenue Next Year
$6.97
N/A
P/E Ratio
$3.68
$5.53
Revenue Growth
N/A
N/A
52 Week Low
$3.15
$2.77
52 Week High
$6.57
$15.55

Technical Indicators

Market Signals
Indicator
IMPP
EMBC
Relative Strength Index (RSI) 58.00 72.42
Support Level $4.64 $3.01
Resistance Level $5.30 $9.38
Average True Range (ATR) 0.22 0.27
MACD 0.03 0.00
Stochastic Oscillator 63.89 92.27

Price Performance

Historical Comparison
IMPP
EMBC

About IMPP Imperial Petroleum Inc.

Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: